Sisram Medical reports 32% profit drop despite growth

Sisram Medical Ltd reported revenue of $165.5 million for the six months ended June 30, down 1.9% from $168.7 million in 2024. Profit plunged 31.9% to $9.0 million from $13.2 million.

However, the APAC region delivered strong growth with revenue rising 17.6% to $65.8 million. The injectables product line surged 218.1% to $14.4 million.

Adjusted net profit fell 28.1% to $12.0 million, with the margin declining to 7.2% from 9.9%. The board declared no interim dividend.